Skip to content
10-Q

Quarterly Report

POINT BIOPHARMA GLOBAL INC.

0001811764-22-000050

← back to feed
Filed
May 13, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 9, 2022 90.12M sh
Cash And Equivalents Q1 2022 · Mar 31, 2022 $227.39M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $238.82M
Current Liabilities Q1 2022 · Mar 31, 2022 $13.64M
Current Liabilities Q1 2022 · Dec 31, 2021 $7.98M
Total Liabilities Q1 2022 · Mar 31, 2022 $13.71M
Total Liabilities Q1 2022 · Dec 31, 2021 $8.05M
Current Assets Q1 2022 · Mar 31, 2022 $232.61M
Current Assets Q1 2022 · Dec 31, 2021 $243.85M
Total Assets Q1 2022 · Mar 31, 2022 $252.98M
Total Assets Q1 2022 · Dec 31, 2021 $263.26M
Shares Diluted Q1 2022 · Mar 31, 2021 56.67M sh
Dividends Paid Q1 2022 · Mar 31, 2021 $0
Capex Q1 2022 · Mar 31, 2021 $186.8K
Operating Cash Flow restated Q1 2022 · Mar 31, 2021 −$10.97M
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.10
Eps Basic Q1 2022 · Mar 31, 2021 −$0.10
Sga Expense Q1 2022 · Mar 31, 2021 $1.46M
Rd Expense Q1 2022 · Mar 31, 2021 $4.27M
Net Income restated Q1 2022 · Mar 31, 2021 −$5.78M
Operating Income restated Q1 2022 · Mar 31, 2021 −$5.73M